Key facts
- Notable investors include Machina Record, Nippon Steel, Sevenwoods Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for cBioinformatics
- ·The full record, as it builds
Funding rounds
No funding rounds for cBioinformatics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About cBioinformatics
Developer of a genome medicine designed to create efficient treatment methods and diagnostic drugs. The company offers a medicine analysis that combines genome and genomics analysis technology and clinical knowledge to spread genomic medicine, enabling medical professionals and medical institutions to create precision medicine for cancer treatment.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2019
- Employees
- 20
- Website
- cbioinformatics.com/
- Ownership
- Privately Held (backing)
cBioinformatics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in cBioinformatics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on cBioinformatics in its N-PORT filings yet. We sweep new filings monthly.